Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2008
12/11/2008WO2008033643A3 Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
12/11/2008US20080306279 Synthesis Intermediates Useful For Preparing Zolmitriptan
12/11/2008US20080306257 Syntheses and Preparations of Narwedine and Related Novel Compounds
12/11/2008US20080306108 Substituted Pyridoxines As Anti-Platelet Agents
12/11/2008US20080306103 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
12/11/2008US20080306098 Pharmacokinetics of protease inhibitors and other drugs
12/11/2008US20080306085 Non-imidazole aryloxyalkylamines
12/11/2008US20080306053 Modulation of chemosensory receptors and ligands associated therewith
12/10/2008EP2000540A2 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer
12/10/2008CN101321766A Substituted benzofused derivatives and their use as vanilloid receptor ligands
12/10/2008CN101321765A Chromone derivatives useful as antagonists of VR1 receptors
12/10/2008CN101318964A Novel crystal system of irinotecan hydrochloride and preparation method thereof
12/10/2008CN101318958A Midbody for preparing spiroindolinepiperidine derivatives
12/10/2008CN100441574C Tricyclic compounds, their production and use
12/09/2008US7462705 Nucleic acids encoding an enediyne polyketide synthase complex
12/09/2008US7462627 Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
12/09/2008US7462625 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
12/09/2008US7462624 Purinone derivatives as HM74a agonists
12/09/2008US7462623 Quinazoline derivatives as Src tyrosine kinase inhibitors
12/09/2008US7462608 Non nucleoside reverse transcriptase inhibitors
12/04/2008WO2008147547A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
12/04/2008WO2008147544A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
12/04/2008US20080300348 Polymer
12/04/2008US20080300236 Quinoline-derived amide modulators of vanilloid vr1 receptor
12/04/2008US20080300200 Therapeutic Furopyrimidines and Thienopyrimidines
12/04/2008CA2687608A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
12/03/2008EP1997811A2 Indazole, benzoxazole and pyrazolopyridine derivatives as P38 kinase inhibitors
12/03/2008EP1997810A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1997809A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1996583A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors)
12/03/2008EP1996573A1 4, 5, 6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
12/03/2008EP1996563A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
12/03/2008EP1996553A2 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
12/03/2008EP1996550A2 Carboxyamine compounds and their use in the treatment of hdac dependent diseases
12/03/2008CN101316592A Indenoisoquinolinone analogs and methods of use thereof
12/03/2008CN101314587A Preparation for midbody of Irinotecan and preparation for Irinotecan
12/03/2008CN100439344C 4-anilino quinazoline derivatives as antiproliferative agents
12/02/2008US7459585 Benzene derivatives and pharmaceutical use thereof
12/02/2008US7459555 2H-naphtho(1,2-b) pyrans photochromatic dyes useful in synthetic resin material (ophthalmic lens)
12/02/2008US7459554 Anticancer agent; 1-(3-Benzyloxy-phenyl)-3-cyclobutyl-imidazo[1,5-a]pyrazin-8-ylamine
12/02/2008US7459478 Substituted dihydropyrano indole-3,4-dione derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
12/02/2008US7459463 Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt
12/02/2008US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism
12/02/2008US7459452 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
12/02/2008US7459451 Pyrazolopyridine derivatives
12/02/2008US7459414 Herbicides
12/02/2008US7459284 Chemiluminescent acridinium compounds and analogues thereof as substrates of hydrolytic enzymes
12/02/2008CA2424600C Aliphatic nitrogenous five-membered ring compounds
11/2008
11/27/2008WO2008143263A1 1-substituted tetrahydroisoquinoline compound
11/27/2008WO2008142542A2 Processes for preparing benzofuro [3, 2-c] pyridine- 9-carbaldehyde derivatives as novel intermediates for the synthesis of pde iv inhibitors
11/27/2008WO2008141731A2 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
11/27/2008WO2008083367A3 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
11/27/2008WO2008013997A3 Fluorescent substrates for monoamine transporters as optical false neurotransmitters
11/27/2008WO2007143468A3 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
11/27/2008US20080293755 Steroidal alkaloids that can be used in the treatment of hedgehog pathway related disorders, particularly cancer and psoriasis
11/27/2008US20080293650 Fused Heterocyclic Compounds and Use Thereof
11/27/2008US20080293573 Use as pesticide, microbiocide, or herbicide
11/27/2008US20080290329 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds
11/27/2008US20080290034 Bridged macrocyclic module compositions
11/27/2008CA2687958A1 1-substituted tetrahydroisoquinoline compound
11/26/2008EP1995249A1 Camptothecin derivatives and their use
11/26/2008EP1994017A2 Novel heterocyclic nf-kb inhibitors
11/26/2008EP1994015A1 Dibenzyl amine derivatives as cetp inhibitors
11/26/2008EP1534707B9 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/26/2008EP1311487B1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
11/26/2008CN101312979A Pyrimidine compounds for the treatment of inflammatory disorders
11/26/2008CN101312976A Spirocyclic compounds as hdac inhibitors
11/26/2008CN100436454C Novel harringtonlne derivative, method for making same and its pharmaceutical composition and use thereof
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436445C Pyrazole derivative
11/26/2008CN100436425C Fused imidazolium derivatives
11/25/2008US7456567 organic electroluminescent device having a pair of electrodes, and at least one organic layer interposed between the pair of electrodes, with the organic layer containing at least one compound represented by formula (1):** Image-1
11/25/2008US7456203 for treatment/prevention of chronic obstructive pulmonary disease, chronic bronchitis, irritable bowel syndrome, and urinary incontinence
11/25/2008US7456192 3β-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof
11/25/2008US7456187 Cardiac arrythmias; 5-Phenyl-N-(pyridin-2-ylmethyl)furo[2,3-d]pyrimidin-4-amine
11/25/2008US7456186 Diphenylimidazopyrimidines as inhibitors of β-secretase
11/25/2008US7456178 Compounds, methods and pharmaceutical compositions for inhibiting PARP
11/25/2008US7456169 Heterocyclic kinase inhibitors
11/25/2008US7456162 Benzofuran derivatives, their production and use
11/25/2008CA2224369C Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use
11/20/2008WO2007109661A3 Methods of preparation and resolution of e/z isomers of vinylfuro[2,3-d] pyrimidine and their biological activities
11/20/2008US20080287504 Such as N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; Cannabinoid-1 (CB1) receptor; dietetics
11/20/2008US20080287466 4-amino-2,3-disubstituted thieno [2,3,d]pyrimidines and pharmaceutical compositions thereof
11/20/2008US20080287465 Cyclic N-Hydroxy Imides as Inhibitors of Flap Endonuclease and Uses Thereof
11/20/2008US20080287450 Novel Substituted Tetracyclic Tetahydrofuran, Pyrrolidine And Tetrahydrothiophene Derivatives
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287420 Cyclopamine lactam analogs and methods of use thereof
11/20/2008US20080287397 Pyrrolopyrimidine Derivatives Substituted with Cyclic Amino Group
11/19/2008EP1992628A1 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
11/19/2008EP1991550A1 Amino pyrimidine compounds for the treatment of inflammatory disorders
11/19/2008CN101309923A N-sulfamoyl-N -benzopyranpiperidines as inhibitors of carbonic anhydrases
11/19/2008CN101306613A Color imaging method
11/18/2008US7452994 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
11/18/2008US7452993 morpholin-4-yl-{3-[3-(1H-pyrazol-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl-phenyl}-methanone; FMS-like tyrosine kinase 3 (FLT3), is implicated in cancers, including leukemia, such as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplasia
11/18/2008US7452900 Esters in position 20 of camptothecins
11/18/2008US7452883 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/13/2008WO2008136374A1 Pharmaceutical composition for inhibiting peripheral neuropathy caused by the administration of anticancer agent
11/13/2008WO2008005908A3 Pyridoimidazole derivatives
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 298